By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Celladon Corporation 

c/o Enterprise Partners Venture Capital
2223 Avenida de la Playa, Suite 300
La Jolla  California  92037  U.S.A.
Phone: 858-731-0241 Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
Celladon (CLDN) Reports Second Quarter 2015 Financial Results 8/12/2015 12:27:02 PM
Celladon (CLDN) Lays Off More Staff, Considers Liquidation in Wake of Gene Therapy Failure 6/26/2015 7:04:45 AM
Celladon (CLDN) Seeks Sale or Partnership and Promotes Paul Cleveland to CEO 6/1/2015 10:36:45 AM
SoCal's Celladon (CLDN) Slashes 50% of Workforce to Conserve Capital After Gene Therapy Fails 5/15/2015 6:56:08 AM
Celladon (CLDN) Reports Negative Results For CUPID2 Trial Of MYDICAR In Advanced Heart Failure 4/27/2015 6:25:21 AM
Celladon (CLDN) Will Lay Off Workers, Loses 80% of Value As Heart Failure Drug Flunks Phase IIb Trial 4/27/2015 6:23:42 AM
Celladon Corporation Reports Fourth Quarter And Year-End 2014 Financial Results And Recent Highlights 3/31/2015 6:55:23 AM
Celladon Corporation To Report Fourth Quarter And Fiscal 2014 Results On March 31 3/26/2015 12:18:27 PM
Novasep And Celladon Corporation Execute MYDICAR API Supply Agreement 3/25/2015 7:32:00 AM
Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/16/2015 7:29:22 AM
12345678910
//-->